{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:43:19Z","timestamp":1793835799573,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR300952"],"award-info":[{"award-number":["NIHR300952"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Healthtech Research Centre in Community Healthcare"},{"name":"Oxford NIHR Biomedical Research Centre and the NIHR Health Protection Research Unit on Antimicrobial Resistance and Healthcare Associated Infection in partnership with the UK Health Security Agency","award":["NIHR200915"],"award-info":[{"award-number":["NIHR200915"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The BRRISC score was developed to predict hospital-attended cellulitis recurrence using clinical data routinely available at presentation. In practice, clinicians assess patients\u2019 response to treatment during the recommended 48-72-hour antibiotic review point when deciding on the duration of antibiotic treatment to achieve lasting recovery. We evaluated the performance of the BRRISC score in an external validation cohort and examined whether incorporating markers of acute clinical response could improve it.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We recruited adults with lower limb cellulitis attending hospital. From days 0\u20133 of treatment, we assessed markers of acute clinical response, including physical examination findings (e.g. affected size, oedema), objective measurements of limb temperature taken with a thermal imaging camera, vital signs, blood test results, and patient-reported symptoms. Outcomes included \u2018hospital-attended recurrence\u2019 (primary outcome for validation) and \u2018any recurrence\u2019 (hospital-attended or community). Using multivariate logistic regression with backwards elimination, we identified response variables independently associated with either outcome that could be included within an extended score. Performance was assessed using the C-index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 202 patients, 8% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200917) experienced \u2018hospital-attended recurrence\u2019 and 23% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200946) \u2018any recurrence\u2019. In this validation dataset, the BRRISC score had a C-index\u2009=\u20090.75 (95%CI, 0.64\u20130.86) for predicting \u2018hospital-attended recurrence\u2019 vs. 0.65 (0.63\u20130.68) in the original development population, but only 0.60 (0.51\u20130.69) for the new outcome \u2018any recurrence\u2019. There was weak evidence that an extended score, incorporating day-2\/3 severity of skin blistering, improved the C-index for \u2018hospital-attended recurrence\u2019 to 0.83 (0.75\u20130.92). No acute clinical response variables were independently associated with \u2018any recurrence\u2019 after adjusting for BRRISC score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The BRRISC score can help identify patients with cellulitis at the highest risk for hospital-attended recurrence. Markers of acute clinical response, typically used by clinicians to inform antibiotic treatment decisions during the 48-72-hour antibiotic review period, did not add helpful prognostic value beyond the baseline factors included in the score. Whether treatment response after day-3 improves recurrence prediction could be further explored, but future research should focus on evaluating the potential for baseline risk stratification to personalise antibiotic duration and guide non-antibiotic approaches for preventing recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12189-3","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:18:05Z","timestamp":1767025085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["External validation of the Baseline Recurrence Risk in Cellulitis (BRRISC) score and the added impact of acute clinical response: a prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Elizabeth L. A.","family":"Cross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail N.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Llewelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"3","key":"12189_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jama.2016.8825","volume":"316","author":"AB Raff","year":"2016","unstructured":"Raff AB, Kroshinsky D, Cellulitis. Rev JAMA. 2016;316(3):325\u201337. https:\/\/doi.org\/10.1001\/jama.2016.8825.","journal-title":"Rev JAMA"},{"issue":"1","key":"12189_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaad.2014.08.043","volume":"72","author":"EY Tay","year":"2015","unstructured":"Tay EY, Fook-Chong S, Oh CC, Thirumoorthy T, Pang SM, Lee HY. Cellulitis recurrence score: a tool for predicting recurrence of lower limb cellulitis. J Am Acad Dermatol. 2015;72(1):140\u20135. https:\/\/doi.org\/10.1016\/j.jaad.2014.08.043.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"12189_CR3","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.cmi.2018.01.023","volume":"24","author":"J Cannon","year":"2018","unstructured":"Cannon J, Dyer J, Carapetis J, Manning L. Epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study. Clin Microbiol Infect. 2018;24(10):1084\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2018.01.023.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"12189_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmi.2019.09.019","volume":"26","author":"DR Cranendonk","year":"2020","unstructured":"Cranendonk DR, Opmeer BC, van Agtmael MA, et al. Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial. Clin Microbiol Infect. 2020;26(5):606\u201312. https:\/\/doi.org\/10.1016\/j.cmi.2019.09.019.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"12189_CR5","doi-asserted-by":"publisher","first-page":"CD009758","DOI":"10.1002\/14651858.CD009758.pub2","volume":"6","author":"A Dalal","year":"2017","unstructured":"Dalal A, Eskin-Schwartz M, Mimouni D, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev. 2017;6(6):CD009758. https:\/\/doi.org\/10.1002\/14651858.CD009758.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"12189_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):147\u201359. https:\/\/doi.org\/10.1093\/cid\/ciu296.","journal-title":"Clin Infect Dis"},{"key":"12189_CR7","unstructured":"National Institute for Health and Care Excellence. Cellulitis and erysipelas: antimicrobial prescribing [NG141]. 2019. https:\/\/www.nice.org.uk\/guidance\/ng141 (accessed November 2024)."},{"key":"12189_CR8","doi-asserted-by":"publisher","unstructured":"Ihm C, Sutton JD, Timbrook TT, Spivak ES. Treatment duration and associated outcomes for skin and soft tissue infections in patients with obesity or heart failure. Open Forum Infect Dis. 2019;6(6). https:\/\/doi.org\/10.1093\/ofid\/ofz217.","DOI":"10.1093\/ofid\/ofz217"},{"issue":"6","key":"12189_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.ajem.2016.02.013","volume":"34","author":"TC Jenkins","year":"2016","unstructured":"Jenkins TC, Knepper BC, McCollister BD, et al. Failure of outpatient antibiotics among patients hospitalized for acute bacterial skin infections: What is the clinical relevance? Am J Emerg Med. 2016;34(6):957\u201362. https:\/\/doi.org\/10.1016\/j.ajem.2016.02.013.","journal-title":"Am J Emerg Med"},{"issue":"7","key":"12189_CR10","doi-asserted-by":"publisher","first-page":"ofac197","DOI":"10.1093\/ofid\/ofac197","volume":"9","author":"S Dellsperger","year":"2022","unstructured":"Dellsperger S, Kramer S, Stoller M, et al. Early switch from intravenous to oral antibiotics in skin and soft tissue infections: an Algorithm-Based prospective multicenter pilot trial. Open Forum Infect Dis. 2022;9(7):ofac197. https:\/\/doi.org\/10.1093\/ofid\/ofac197.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"12189_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/archinte.167.7.709","volume":"167","author":"DR McNamara","year":"2007","unstructured":"McNamara DR, Tleyjeh IM, Berbari EF, et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007;167(7):709\u201315. https:\/\/doi.org\/10.1001\/archinte.167.7.709.","journal-title":"Arch Intern Med"},{"issue":"2","key":"12189_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jinf.2023.12.007","volume":"88","author":"ELA Cross","year":"2024","unstructured":"Cross ELA, Quan TP, Hayward GN, Walker AS, Llewelyn MJ. Development and validation of the baseline recurrence risk in cellulitis (BRRISC) score. J Infect. 2024;88(2):103\u201311. https:\/\/doi.org\/10.1016\/j.jinf.2023.12.007.","journal-title":"J Infect"},{"issue":"8","key":"12189_CR13","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/cid\/ciw463","volume":"63","author":"T Bruun","year":"2016","unstructured":"Bruun T, Oppegaard O, Hufthammer KO, Langeland N, Skrede S. Early response in cellulitis: A prospective study of dynamics and predictors. Clin Infect Dis. 2016;63(8):1034\u201341. https:\/\/doi.org\/10.1093\/cid\/ciw463.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"12189_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12916-020-01660-4","volume":"18","author":"LSJ Roope","year":"2020","unstructured":"Roope LSJ, Buchanan J, Morrell L, et al. Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey. BMC Med. 2020;18(1):196. https:\/\/doi.org\/10.1186\/s12916-020-01660-4.","journal-title":"BMC Med"},{"issue":"15","key":"12189_CR15","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","volume":"164","author":"MJ Hepburn","year":"2004","unstructured":"Hepburn MJ, Dooley DP, Skidmore PJ, Ellis MW, Starnes WF, Hasewinkle WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med. 2004;164(15):1669\u201374. https:\/\/doi.org\/10.1001\/archinte.164.15.1669.","journal-title":"Arch Intern Med"},{"issue":"9","key":"12189_CR16","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s11606-018-4546-z","volume":"33","author":"CG Gunderson","year":"2018","unstructured":"Gunderson CG, Cherry BM, Fisher A. Do patients with cellulitis need to be hospitalized? A systematic review and Meta-analysis of mortality rates of inpatients with cellulitis. J Gen Intern Med. 2018;33(9):1553\u201360. https:\/\/doi.org\/10.1007\/s11606-018-4546-z.","journal-title":"J Gen Intern Med"},{"key":"12189_CR17","doi-asserted-by":"publisher","first-page":"b604","DOI":"10.1136\/bmj.b604","volume":"338","author":"P Royston","year":"2009","unstructured":"Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604. https:\/\/doi.org\/10.1136\/bmj.b604.","journal-title":"BMJ"},{"issue":"1","key":"12189_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hpb.2020.07.007","volume":"23","author":"S Buttner","year":"2021","unstructured":"Buttner S, Galjart B, Beumer BR, et al. Quality and performance of validated prognostic models for survival after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. HPB (Oxford). 2021;23(1):25\u201336. https:\/\/doi.org\/10.1016\/j.hpb.2020.07.007.","journal-title":"HPB (Oxford)"},{"key":"12189_CR19","doi-asserted-by":"publisher","unstructured":"DeLong ERDD, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988:44837\u201345. https:\/\/doi.org\/10.2307\/2531595.","DOI":"10.2307\/2531595"},{"key":"12189_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","volume":"13","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015;13:1. https:\/\/doi.org\/10.1186\/s12916-014-0241-z.","journal-title":"BMC Med"},{"key":"12189_CR21","unstructured":"James Lind Alliance Priority Setting Partnerships. Cellulitis Top 10. 2017. https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/cellulitis#tab-26541 (accessed November 2024)."},{"issue":"1","key":"12189_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338. https:\/\/doi.org\/10.1097\/EDE.0b013e3181c30fb2.","journal-title":"Epidemiology"},{"issue":"9","key":"12189_CR23","first-page":"653","volume":"42","author":"M Montalto","year":"2013","unstructured":"Montalto M, Davies F, Marijanovic N, Meads A. Skin surface temperature: a possible new outcome measure for skin and soft tissue infection. Aust Fam Physician. 2013;42(9):653\u20137.","journal-title":"Aust Fam Physician"},{"issue":"4","key":"12189_CR24","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s15010-022-01842-7","volume":"50","author":"K Yadav","year":"2022","unstructured":"Yadav K, Krzyzaniak N, Alexander C, et al. The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a systematic review and meta-analysis. Infection. 2022;50(4):859\u201371. https:\/\/doi.org\/10.1007\/s15010-022-01842-7.","journal-title":"Infection"},{"key":"12189_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad488","author":"OM Williams","year":"2023","unstructured":"Williams OM, Hamilton F, Brindle R. Open Forum Infect Dis. 2023;10(10):ofad488. https:\/\/doi.org\/10.1093\/ofid\/ofad488. The Natural History of Antibiotic-Treated Lower Limb Cellulitis: Analysis of Data Extracted From a Multicenter Clinical Trial."},{"issue":"4","key":"12189_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/1742-6723.14401","volume":"36","author":"RS Nightingale","year":"2024","unstructured":"Nightingale RS, Etheridge N, Sweeny AL, et al. Cellulitis in the emergency department: A prospective cohort study with patient-centred follow-up. Emerg Med Australas. 2024;36(4):579\u201388. https:\/\/doi.org\/10.1111\/1742-6723.14401.","journal-title":"Emerg Med Australas"},{"issue":"Suppl 1","key":"12189_CR27","doi-asserted-by":"publisher","first-page":"i51","DOI":"10.1093\/jac\/dks202","volume":"67","author":"D Ashiru-Oredope","year":"2012","unstructured":"Ashiru-Oredope D, Sharland M, Charani E, McNulty C, Cooke J, Group AAS. Improving the quality of antibiotic prescribing in the NHS by developing a new antimicrobial stewardship programme: start Smart\u2013Then focus. J Antimicrob Chemother. 2012;67(Suppl 1):i51\u201363. https:\/\/doi.org\/10.1093\/jac\/dks202.","journal-title":"J Antimicrob Chemother"},{"key":"12189_CR28","volume-title":"Core elements of hospital antibiotic stewardship programs","author":"Centers for Disease Control and Prevention","year":"2014","unstructured":"Centers for Disease Control and Prevention. Core elements of hospital antibiotic stewardship programs. Atlanta, GA: US Department of Health and Human Services, CDC; 2014."},{"key":"12189_CR29","volume-title":"Guidance for Industry. Acute bacterial skin and skin structure infections: developing drugs for treatment","author":"US Food and Drug Administration","year":"2013","unstructured":"US Food and Drug Administration. Guidance for Industry. Acute bacterial skin and skin structure infections: developing drugs for treatment. Maryland: US Food and Drug Administration; 2013."},{"issue":"5","key":"12189_CR30","doi-asserted-by":"publisher","first-page":"ofad214","DOI":"10.1093\/ofid\/ofad214","volume":"10","author":"JA Amendola","year":"2023","unstructured":"Amendola JA, Segre AM, Miller AC, et al. Using thermal imaging to track cellulitis. Open Forum Infect Dis. 2023;10(5):ofad214. https:\/\/doi.org\/10.1093\/ofid\/ofad214.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"12189_CR31","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1007\/s11606-023-08229-w","volume":"38","author":"R Nightingale","year":"2023","unstructured":"Nightingale R, Yadav K, Hamill L, et al. Misdiagnosis of uncomplicated cellulitis: a systematic review and Meta-analysis. J Gen Intern Med. 2023;38(10):2396\u2013404. https:\/\/doi.org\/10.1007\/s11606-023-08229-w.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"12189_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/jhm.12977","volume":"18","author":"TS Cutler","year":"2023","unstructured":"Cutler TS, Jannat-Khah DP, Kam B, Mages KC, Evans AT. Prevalence of misdiagnosis of cellulitis: A systematic review and meta-analysis. J Hosp Med. 2023;18(3):254\u201361. https:\/\/doi.org\/10.1002\/jhm.12977.","journal-title":"J Hosp Med"},{"issue":"4","key":"12189_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jinf.2020.07.030","volume":"81","author":"ELA Cross","year":"2020","unstructured":"Cross ELA, Jordan H, Godfrey R, et al. Route and duration of antibiotic therapy in acute cellulitis: A systematic review and meta-analysis of the effectiveness and harms of antibiotic treatment. J Infect. 2020;81(4):521\u201331. https:\/\/doi.org\/10.1016\/j.jinf.2020.07.030.","journal-title":"J Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12189-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12189-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12189-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:18:07Z","timestamp":1767025087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12189-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12189"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12189-3","relation":{"references":[{"id-type":"doi","id":"10.1093\/ofid\/ofad488","asserted-by":"subject"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and approved by the East of Scotland Research Ethics Service, Research Ethics Committee (21\/ES\/0048). Informed consent was obtained from all participants prior to their involvement in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1761"}}